BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27522093)

  • 1. Assessment of bone mineral density and bone metabolism in young male adults recently diagnosed with systemic lupus erythematosus in China.
    Guo Q; Fan P; Luo J; Wu S; Sun H; He L; Zhou B
    Lupus; 2017 Mar; 26(3):289-293. PubMed ID: 27522093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupled bone remodeling is characteristic of bone damage in premenopausal women with new-onset systemic lupus erythematosus.
    Zhu L; Zhang J; Wang J; Lv X; Pu D; Wang Y; Men Q; He L
    Lupus; 2021 Jun; 30(7):1116-1123. PubMed ID: 33832361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum fibroblast growth factor-23 and decreased bone turnover in patients with systemic lupus erythematosus under treatment with cyclosporine and steroid but not steroid only.
    Lai CC; Chen WS; Chang DM; Tsao YP; Wu TH; Chou CT; Tsai CY
    Osteoporos Int; 2015 Feb; 26(2):601-10. PubMed ID: 25270396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone turnover markers in relation to vitamin D status and disease activity in adults with systemic lupus erythematosus.
    Sarkissian A; Sivaraman V; Bout-Tabaku S; Ardoin SP; Moore-Clingenpeel M; Mruk V; Steigelman H; Morris K; Bowden SA
    Lupus; 2019 Feb; 28(2):156-162. PubMed ID: 30509154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of bone mineral density and serum bone turnover markers in newly diagnosed systemic lupus erythematosus patients].
    Yao HH; Tang SM; Wang ZM; Zhang X; Chen XY; Gao L; Liu J; Dai YJ; Hu ZH; Zhang XW; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):998-1003. PubMed ID: 30562771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone metabolism and bone mineral density of systemic lupus erythematosus at the time of diagnosis.
    Teichmann J; Lange U; Stracke H; Federlin K; Bretzel RG
    Rheumatol Int; 1999; 18(4):137-40. PubMed ID: 10220833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus.
    Redlich K; Ziegler S; Kiener HP; Spitzauer S; Stohlawetz P; Bernecker P; Kainberger F; Grampp S; Kudlacek S; Woloszczuk W; Smolen JS; Pietschmann P
    Ann Rheum Dis; 2000 Apr; 59(4):308-10. PubMed ID: 10733481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood-onset disease carries a higher risk of low bone mineral density in an adult population of systemic lupus erythematosus.
    Mok CC; Wong SN; Ma KM
    Rheumatology (Oxford); 2012 Mar; 51(3):468-75. PubMed ID: 22096013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and possible risk factors of low bone mineral density in untreated female patients with systemic lupus erythematosus.
    Sun YN; Feng XY; He L; Zeng LX; Hao ZM; Lv XH; Pu D
    Biomed Res Int; 2015; 2015():510514. PubMed ID: 25738154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
    Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
    Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus].
    Becker A; Fischer R; Schneider M
    Z Rheumatol; 2001 Oct; 60(5):352-8. PubMed ID: 11759235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relationship of vitamin D endocrine system and estrogen receptor expression with bone mineral density in initial systemic lupus erythematosus].
    Zheng YJ; Chen S; Li ZQ; Yuan M; Ao W; Bao CD; Hu DW
    Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):309-12. PubMed ID: 20627037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women.
    Sinigaglia L; Varenna M; Binelli L; Zucchi F; Ghiringhella D; Gallazzi M; Limonta M; Zeni S; Fantini F
    J Rheumatol; 1999 Jun; 26(6):1280-4. PubMed ID: 10381043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [THE LEVELS OF OSTEOCALCIN AND PYRIDINOLINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE RELATIONSHIP WITH STRUCTURAL AND FUNCTIONAL STATE OF BONE TISSUE AND COURSE OF THE DESEASE].
    Shevchuk SV; Denyschych LP
    Lik Sprava; 2015; (7-8):57-65. PubMed ID: 27491152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lumbar spine bone mineral density predicts endothelial reactivity in patients with systemic lupus erythematosus.
    Mak A; Ling LH; Ho RC; Gong L; Cheak AA; Yee H; Vasoo S; Koh DR; Robless PA
    Clin Exp Rheumatol; 2011; 29(2):261-8. PubMed ID: 21385541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic Acquired Osteosclerosis in a Middle-Aged Woman With Systemic Lupus Erythematosus.
    Guañabens N; Mumm S; Gifre L; Ruiz-Gaspà S; Demertzis JL; Stolina M; Novack DV; Whyte MP
    J Bone Miner Res; 2016 Sep; 31(9):1774-82. PubMed ID: 27005479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of bone mineral density and selected metabolic markers of bone in boys with constitutional delay of growth and puberty].
    Krupa B
    Ann Acad Med Stetin; 2000; 46():165-76. PubMed ID: 11712302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower P1NP serum levels: a predictive marker of bone loss after 1 year follow-up in premenopausal systemic lupus erythematosus patients.
    Seguro LP; Casella CB; Caparbo VF; Oliveira RM; Bonfa A; Bonfa E; Pereira RM
    Osteoporos Int; 2015 Feb; 26(2):459-67. PubMed ID: 25146092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus.
    Bultink IE; Lems WF; Kostense PJ; Dijkmans BA; Voskuyl AE
    Arthritis Rheum; 2005 Jul; 52(7):2044-50. PubMed ID: 15986345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between long-term use of a typical antipsychotic medication by Chinese schizophrenia patients and the bone turnover markers serum osteocalcin and β-CrossLaps.
    Zhang B; Deng L; Wu H; Lu X; Peng L; Wu R; Guo W; Chen J; Li L; Zhao J
    Schizophr Res; 2016 Oct; 176(2-3):259-263. PubMed ID: 27377977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.